«Grindeks» has all required resources to ensure research and development of the both active pharmaceutical ingredients and final dosage medications in compliance with the international quality standards at affordable prices:
- cGMP, GLP, GCP, eCTD, CTD;
- modern technologies, laboratories and production facilities;
- legal competence;
- 70 highly qualified and competent staff members.
«Grindeks» succeeded in co-operation with Latvian scientific and research institutes as well as with foreign pharmaceutical companies in fulfilment of a number of scientific projects contributing to new substances research and development.
The company's Development department is responsible for:
The Development department is focusing all efforts on fractional product life-cycle parts and improves the process of vertical integration in the development stage between APIs and FDFs.